Adema, Gosse J.
Radboud University Medical Center,
Netherlands
2025 Rank: 68337
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1281 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 68337 | 76197 |
| Total Cites | 1363 | 1472 |
| H-index | 18 | 18 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 15 | 15 |
| Number of Single+First+Last Authored Papers | 146 | 146 |
| Total Cites to Single+First+Last Authored Papers | 765 | 794 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1123 | 1181 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.25 |
| Self-Citation Percentage |
7.40%
|
|
Adema, Gosse J.
Radboud University Medical Center,
Netherlands
2024 Rank: 64857
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1304 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 64857 | 76006 |
| Total Cites | 1387 | 1477 |
| H-index | 17 | 17 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 13 | 13 |
| Number of Single+First+Last Authored Papers | 143 | 143 |
| Total Cites to Single+First+Last Authored Papers | 746 | 768 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1169 | 1215 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.22 |
| Self-Citation Percentage |
6.09%
|
|
Adema, Gosse J.
Radboud University Medical Center,
Netherlands
2023 Rank: 51218
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1132 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 51218 | 53533 |
| Total Cites | 1498 | 1632 |
| H-index | 18 | 19 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 5 | 5 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 15 | 15 |
| Number of Single+First+Last Authored Papers | 141 | 141 |
| Total Cites to Single+First+Last Authored Papers | 772 | 822 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1235 | 1295 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.26 |
| Self-Citation Percentage |
8.21%
|
|
Adema, Gosse J.
Radboud Institute for Molecular Life Sciences,
Netherlands
2022 Rank: 38610
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 995 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 38610 | 40739 |
| Total Cites | 1614 | 1744 |
| H-index | 21 | 21 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 8 | 8 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 18 | 18 |
| Number of Single+First+Last Authored Papers | 136 | 136 |
| Total Cites to Single+First+Last Authored Papers | 827 | 872 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1323 | 1386 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.26 |
| Self-Citation Percentage |
7.45%
|
|
Adema, Gosse J.
Radboud University Nijmegen Medical Centre,
Netherlands
2021 Rank: 41232
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 987 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 41232 | 43709 |
| Total Cites | 2246 | 2452 |
| H-index | 25 | 26 |
| Hm-index | 8 | 9 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 9 | 9 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 31 | 31 |
| Number of Single+First+Last Authored Papers | 132 | 132 |
| Total Cites to Single+First+Last Authored Papers | 1133 | 1211 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1863 | 1947 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.26 |
| Self-Citation Percentage |
8.40%
|
|
Adema, Gosse J.
Radboud University Nijmegen Medical Centre,
Netherlands
2020 Rank: 47893
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1042 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 47893 | 54498 |
| Total Cites | 1530 | 1702 |
| H-index | 19 | 19 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 25 | 25 |
| Number of Single+First+Last Authored Papers | 128 | 128 |
| Total Cites to Single+First+Last Authored Papers | 738 | 804 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1264 | 1318 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.29 |
| Self-Citation Percentage |
10.11%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.